The India Brand Equity Foundation (IBEF), on behalf of the Government of India and several major pharmaceutical industry organizations, has formed the India – Responsible Healthcare Trust, aimed at empowering the Brand India Pharma campaign. The public-private partnership represents the commitment to both drive and safeguard the interests of the Indian pharma industry and to position India as a Responsible Healthcare provider.
 
The Trust comprises key stakeholders, namely, the Indian Pharmaceutical Alliance (IPA), Indian Drug Manufacturers’ Association (IDMA), Bulk Drug Manufacturers Association (BDMA), Association of Biotechnology Led Enterprises (ABLE), Pharmaceutical Export Promotion Council of India (Pharmexcil) and India Brand Equity Foundation (IBEF). The Trust aims to combine resources towards a common agenda aimed at creating better awareness and develop an informed perspective about Brand India Pharma in both the domestic and global markets.
 
“The India – Responsible Healthcare Trust will spearhead the Brand India Pharma initiative through the second phase. The industry-government partnership is an important milestone in the campaign,” said Rajeev Kher, Commerce Secretary, Government of India.
 
The Brand India Pharma campaign was launched under the aegis of the Department of Commerce at CPhI Japan in March 2012.